FS Development Holdings II LLC 13D and 13G filings for Pardes Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-31 5:17 pm Sale | 2023-08-31 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 1,000 100.000% | -16,812,146 (-99.99%) | Filing |
| 2023-07-17 07:55 am Unchanged | 2023-07-16 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 16,813,146 27.240% | 0 (Unchanged) | Filing |
| 2023-04-21 4:28 pm Unchanged | 2023-04-20 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 16,813,146 27.240% | 0 (Unchanged) | Filing |
| 2023-04-06 9:07 pm Purchase | 2023-04-05 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 16,813,146 27.240% | 1,547,904 (+10.14%) | Filing |
| 2022-12-05 4:23 pm Purchase | 2022-12-01 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 15,265,242 24.490% | 637,420 (+4.36%) | Filing |
| 2021-12-30 5:09 pm Purchase | 2021-12-23 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 14,627,822 23.450% | 14,627,822 (New Position) | Filing |